HANNAH KLOHA: Open Payments
NPI 1861085110 · MIDLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 50 payments from 9 companies in 2025. Trend: 2023 $1,506 · 2024 $1,717 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $500 |
| Lundbeck LLC | 7 | $218 |
| Teva Pharmaceuticals USA, Inc. | 5 | $199 |
| E.R. Squibb & Sons, L.L.C. | 4 | $139 |
| Alkermes, Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 1 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, COBENFY, UZEDY, ARISTADA, Auvelity, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
